covid 19 drug

Non-steroidal anti-inflammatory drug Indomethacin has shown excellent efficacy in the treatment of mild and moderate COVID-19 patients during the trial. It was designed by (IIT) Madras. The study further revealed that…

United Nations-backed public health organisation Medicines Patent Pool (MPP) has signed sublicence agreements with 10 generic drugmakers in India for the manufacturing of COVID-19 antiviral oral drug molnupiravir and supply in 105 low-…

<!-- -->AstraZeneca has already submitted an application to US regulators for approval of its Covid drug (File)London: Pharmaceutical giant AstraZeneca on Thursday announced that clinical trials of an antibody-based COVID-19 drug had…

<!-- -->Merck has entered into licensing agreements with at least eight Indian drugmakers for molnupiravir (File)Bengaluru: Two drugmakers in the country have requested permission to end their late-stage trials on Merck & Co's…

AstraZeneca has requested emergency use authorization from U.S. regulators for its new treatment to prevent COVID-19 for people who respond poorly to vaccines because of a weakened immune system. In a statement on Tuesday, the…

A biosimilar version of Roche’s Actemra/RoActemra, product will be available by month end. Drugmaker Hetero’s generic version of Tocilizumab has recieved Emergency Use Authorisation (EUA) from the Drugs Controller General of India…

There is a little-known drug developing company called iSERA Biological Pvt Ltd that is making big waves lately. The bioscience company which is based near Kolhapur, in Pune Maharashtra, is testing a new drug that is gunning to be the first…